Medullary thyroid cancer: molecular biology and novel molecular therapies.
Medullary thyroid cancer (MTC) arises from neural-crest-derived parafollicular C cells of the thyroid gland and accounts for approximately 4% of all thyroid cancers. Up to 25-30% of MTC cases occur as inherited disorders while the remaining cases represent the sporadic form of the disease. In this r...
Main Authors: | Cakir, M, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Update on Targeted Therapy in Medullary Thyroid Cancer
by: Christian Okafor, et al.
Published: (2021-08-01) -
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
by: Ana Luiza Maia, et al.
Published: (2011-12-01) -
A Brief Review on The Molecular Basis of Medullary Thyroid Carcinoma
by: Mohammadi Masoumeh, et al.
Published: (2016-11-01) -
Current status of the prognostic molecular markers in medullary thyroid carcinoma
by: Malgorzata Oczko-Wojciechowska, et al.
Published: (2020-12-01) -
Targeted Therapy for Medullary Thyroid Cancer: A Review
by: S. R. Priya, et al.
Published: (2017-10-01)